Full Text View
Tabular View
Study Results
Related Studies
An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis
This study has been completed.
Study NCT00402688   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: November 21, 2006   Last Updated: July 21, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostatitis
Additional conditions recognized in this trial
Chronic Disease
More general conditions related to this trial
Disease Attributes
Genital Diseases, Male
Pathologic Processes
Prostatic Diseases
Interventions listed in this trial
levofloxacin
Additional drug interventions recognized in this trial
Ofloxacin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Urinary
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
PriCara, Unit of Ortho-McNeil, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services